Impact of COVID-19 on Europe’s Capital Markets: Market Update

AFME published, in July 2020, a new research note on the “Impact of COVID-19 on European Capital Markets: Market Update”.

The purpose of this report is to provide an update on how European capital markets have performed during the COVID-19 outbreak. This report follows a first publication launched in mid-April which assessed the initial impact of COVID-19 on Europe’s capital markets.

Key findings:

  • Issuance levels of investment grade (IG) bonds have reached record weekly, monthly and quarterly volumes.
  • An ESG recovery.
  • European market liquidity has deteriorated over the last few months.
  • Follow on equity offerings have continued to support the recovery.
  • After two months of a virtually inactive IPO market, the European primary equity market reopened in May with EUR 3.6bn in proceeds from 24 deals.
  • European listed SMEs have also benefited from access to equity capital, predominantly from secondary offerings on Junior exchanges.
  • Record volumes of bank lending.

Read Full Report Here

Are you an emerging Organisation?
We are Here To support You

Have additional questions?

Feel free to contact us under community@eban.org, and we will be more than happy to answer all of your questions.

Regular Price for Angel Networks
1.500€ per year
Price for Emerging Networks
1.000€ per year*
*Networks with less than 200 members or less than 10M invested per year
Regular Price for Angel Federations
2.500€ per year
Price for Emerging Federations
1.500€ per year*
*Federations with less than 200 affiliated angels or less than 3 BANs, VCs, or syndicates be part of their network
Regular Price for Early Stage Funds
2.500€ per year
Price for Emerging Early Stage Funds
1.500€ per year*
*Early Stage Funds with less than 20M AUM
Regular Price for Funding Platforms
2.500€ per year
Price for Emerging Funding Platforms
1.500€ per year*
*Platforms with less than 20M Euros of transactions made